Evidence map›Paper›PMID 40906456›Full record

ArticleAdvanced healthcare materials2025

Induction of Nephron-Ductal Dual Lineages via Early Retinoic Acid Signaling Establishes a Platform for Fully Patterned Kidney Organoids.

Jung Hwa Lim, Seeun Kim, Dong Hyun Lee, Dae Hun Kim, Hye Bin Lee, Ye Seul Son, Mi-Young Son, Soo Jin Oh, Ji-Yoon Lee, Mi-Ok Lee and 4 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Retinoic acid in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jung Hwa LimStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Seeun KimStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Dong Hyun LeeStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Dae Hun KimStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Hye Bin LeeStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Ye Seul SonStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Mi-Young SonStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Soo Jin OhAsan Institute for Life Sciences, Asan Medical Center & Department of Convergence Medicine, College of Medicine, University of Ulsan, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Ji-Yoon LeeAsan Institute for Life Sciences, Asan Medical Center & Department of Convergence Medicine, College of Medicine, University of Ulsan, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.
Mi-Ok LeeStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Hyun Soo ChoStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Dae-Soo KimKRIBB School of Bioscience, Korea University of Science and Technology (UST), 217 Gajeong-ro, Daejeon, 34129, Republic of Korea.
Cho-Rok JungStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.
Hyun Mi KangStem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.ORCID 0000-0002-2483-0776

Funding

Korea Research Institute of Bioscience and Biotechnology 2710087137National Institute of Health research project 2023-ER1102-00National Research Foundation of Korea RS-2025-00562377
6 · The paper itself

Abstract

Kidney organoids are powerful tools for renal disease modeling and nephrotoxicity screening, yet their limited structural complexity-particularly the underdevelopment of ureteric bud (UB) lineages-remains a major limitation. A novel differentiation protocol is developed that short-term activation of retinoic acid (RA) signaling during the early intermediate mesoderm (IM) stage, enabling co-induction of anterior and posterior IM lineages. This eliminates the need for UB co-culture and supports the formation of kidney organoids containing complete nephron segments. BMP7 treatment during the maturation phase mimics UB-derived signals, further enhancing tubular maturation. Single-cell transcriptomic analysis confirms that RA activation promotes dual IM induction at early stages, while BMP7 enhances organoid maturity. These dual IMs enable the generation of tubule and collecting duct organoids, which serve as segment-specific models for renal reabsorption, efflux, and nephron-targeted drug response assessment. Furthermore, the organoids are integrated into a networking cell culture system with enterocytes and hepatocytes, establishing a physiologically integrated model for systemic drug evaluation. This platform enables more accurate in vitro analysis of drug absorption, metabolism, and nephrotoxicity, including NSAID-induced injury. Overall, this approach offers a robust, scalable, and physiologically relevant platform for next-generation renal modeling and pharmacological research.

Indexed as

KidneyNephronsOrganoidsSignal TransductionTretinoinAnimalsBone Morphogenetic Protein 7Cell DifferentiationCell LineageHumansMiceBone Morphogenetic Protein 7Tretinoinanterior and posterior intermediate mesodermbone morphogenetic protein 7collecting ductfull segmented kidney organoidretinoic acid

Identifiers

PMID40906456
PMCPMC12683206

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.